Today, Paul and Mike unpack their opinions about lipids. They talk about true risk for cardiovascular disease, primary versus secondary prevention, lipid lowering drugs, and share their thoughts on a recent podcast episode with Peter Attia.


*Produced by Mountain Valley Media


00:06:08 Blood markers & imaging techniques of metabolic function 

00:14:38 Gene mutations

00:20:28 LDL & Plaque burden

00:27:23 Money in statins

00:31:38 Downsides of lowering LDL

01:21:23 The downsides of popular cholesterol lowering drugs

01:41:07 Should we fear heart attacks?

01:45:23 PCSK9 Inhibitors

01:52:43 Risk profile of Statins 

01:53:02 Risk vs. reward of Ezetimibe

02:04:02 Primary vs. secondary prevention


Resources:

Debunking Sugar Claims: What Dr. Lustig Got Wrong On The Huberman Podcast:

https://www.youtube.com/watch?v=JcEmSgbMfco&t=2933s


Work With Mike: https://mikefave.com/


Podden och tillhörande omslagsbild på den här sidan tillhör Paul Saladino, MD. Innehållet i podden är skapat av Paul Saladino, MD och inte av, eller tillsammans med, Poddtoppen.